Strategies to design potential FBXW8 inhibitors, by structure‐based drug design, have been reported.[27] NUMB expression in BC might provide a useful stratification criterion for preclinical and eventually clinical studies with these compounds. The gene discussed is NUMB; the disease is breast cancer.